Investors' long-held "fear of missing out" is now vying with their "fear of wipeout", creating a peculiar situation in which ...
Updated interim results with an additional ~19 weeks of follow-up since the prior update [212Pb]VMT-α-NET continues to be well-tolerated Objective Response Rate of 44% (7 of 16 patients) in Cohort 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback